West London Vascular & Interventional Centre (WeLVIC), Northwick Park Hospital, Harrow, UK.
Ann Vasc Surg. 2021 May;73:369-374. doi: 10.1016/j.avsg.2020.11.021. Epub 2021 Jan 12.
Percutaneous endovascular aneurysm repair (pEVAR) is commonly utilized and requires the use of suture-mediated closure (SMC) devices to ensure adequate femoral artery hemostasis. Despite the use of such devices, puncture-related complications remain relatively common. We introduced two new adjuncts (pledget reinforcement and tractional compression) along with SMC to reduce such puncture-related complications. The aim of the study was to assess the efficacy and safety of the new adjunct techniques.
This retrospective observational cohort study examines the impact of two adjunctive techniques on puncture-related complications compared with the previous year data before this new introduction of adjunct techniques.
Sixty-one percutaneous femoral punctures (in 31 patients) utilizing adjunct techniques for closure (the adjunct group) were retrospectively compared with 89 punctures (in 46 patients) closed with standard SMC technique (the standard group). The use of adjunctive techniques led to a significant reduction in overall puncture-related complications (3/61 (4.9%) vs. 20/89 (22.5%), P = 0.0106) and the need for emergent surgical repair after failed hemostasis (2/61 (3.3%) vs. 13/89 (14.6%), P = 0.037).
These novel adjunctive techniques (pledget reinforcement and tractional compression) of SMC for pEVAR reduce puncture-related complications and increase the confidence to offer percutaneous techniques for more patients.
经皮血管内动脉瘤修复术(pEVAR)被广泛应用,需要使用缝合介导闭合(SMC)装置来确保股动脉充分止血。尽管使用了这些装置,穿刺相关并发症仍相对常见。我们引入了两种新的辅助方法(垫片加固和牵引压迫)与 SMC 一起使用,以减少这些穿刺相关并发症。本研究的目的是评估新辅助技术的疗效和安全性。
这项回顾性观察队列研究比较了两种辅助技术对穿刺相关并发症的影响,并与新引入辅助技术之前的前一年数据进行了比较。
61 例经皮股动脉穿刺(31 例患者)采用辅助技术闭合(辅助组)与 89 例采用标准 SMC 技术闭合(标准组)的穿刺进行了回顾性比较。辅助技术的使用显著降低了总体穿刺相关并发症(3/61(4.9%)比 20/89(22.5%),P=0.0106)和止血失败后需要紧急手术修复的情况(2/61(3.3%)比 13/89(14.6%),P=0.037)。
这些用于 pEVAR 的 SMC 的新辅助技术(垫片加固和牵引压迫)可减少穿刺相关并发症,并增加为更多患者提供经皮技术的信心。